1. Home
  2. TVTX vs DOO Comparison

TVTX vs DOO Comparison

Compare TVTX & DOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$58.16

Market Cap

4.3B

Sector

Health Care

ML Signal

HOLD

Logo BRP Inc. Common Subordinate Voting Shares

DOO

BRP Inc. Common Subordinate Voting Shares

N/A

Current Price

$62.13

Market Cap

4.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
TVTX
DOO
Founded
N/A
1937
Country
United States
Canada
Employees
N/A
17000
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
TVTX
DOO
Price
$58.16
$62.13
Analyst Decision
Strong Buy
Buy
Analyst Count
13
3
Target Price
$40.62
$85.67
AVG Volume (30 Days)
2.2M
221.6K
Earning Date
05-04-2026
05-28-2026
Dividend Yield
N/A
1.21%
EPS Growth
92.89
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$44.76
$8.48
Revenue Next Year
$35.51
$5.10
P/E Ratio
N/A
$338.95
Revenue Growth
N/A
N/A
52 Week Low
$14.36
$48.83
52 Week High
$60.10
$81.89

Technical Indicators

Market Signals
Indicator
TVTX
DOO
Relative Strength Index (RSI) 74.06 60.09
Support Level $41.75 $60.02
Resistance Level N/A $63.86
Average True Range (ATR) 2.35 1.96
MACD 0.61 0.23
Stochastic Oscillator 86.03 74.41

Price Performance

Historical Comparison
TVTX
DOO

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

About DOO BRP Inc. Common Subordinate Voting Shares

BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested; Manitou was sold in the third quarter of fiscal 2026, and Telwater remains up for sale. At the end of fiscal 2026, the company sold its products through a network of more than 2,050 independent dealers and 140 distributors in around 110 countries.

Share on Social Networks: